Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Peer-reviewed

Research Article

Developing a multiplex loop-mediated isothermal amplification assay (LAMP) to determine severe fever with thrombocytopenia syndrome (SFTS) and scrub typhus

  • Woong Sik Jang,

    Roles Conceptualization, Data curation, Validation, Visualization, Writing – original draft

    Affiliation Emergency Medicine, College of Medicine, Korea University Guro Hospital, Seoul, Korea

    ⨯
  • Da Hye Lim,

    Roles Investigation, Methodology

    Affiliation Departments of Laboratory Medicine, College of Medicine, Korea University Guro Hospital, Seoul, Korea

    ⨯
  • Young Lan Choe,

    Roles Data curation, Investigation, Methodology

    Affiliation Departments of Laboratory Medicine, College of Medicine, Korea University Guro Hospital, Seoul, Korea

    ⨯
  • Jeonghun Nam,

    Roles Investigation, Validation

    Affiliations Department of Song‐do Bio Engineering, Incheon Jaeneung University, Incheon, Korea, Artificial Intelligence (AI)‐Bio Research Center, Incheon Jaeneung University, Incheon, Korea

    ⨯
  • Kyung Chul Moon,

    Roles Conceptualization, Data curation, Methodology

    Affiliation Emergency Medicine, College of Medicine, Korea University Guro Hospital, Seoul, Korea

    ⨯
  • Chaewon Kim,

    Roles Validation, Visualization

    Affiliation Departments of Laboratory Medicine, College of Medicine, Korea University Guro Hospital, Seoul, Korea

    ⨯
  • Minkyeong Choi,

    Roles Formal analysis, Investigation

    Affiliation Departments of Laboratory Medicine, College of Medicine, Korea University Guro Hospital, Seoul, Korea

    ⨯
  • Insu Park,

    Roles Formal analysis, Resources

    Affiliation Departments of Laboratory Medicine, College of Medicine, Korea University Guro Hospital, Seoul, Korea

    ⨯
  • Dae Won Park ,

    Roles Conceptualization, Funding acquisition, Project administration, Supervision, Writing – review & editing

    pugae1@korea.ac.kr (DWP); malarim@korea.ac.kr (CSL)

    Affiliation Division of Infectious Diseases, Department of Internal Medicine, Korea University Ansan Hospital, Ansan-si, Gyeonggi-do, Republic of Korea

    ⨯
  • Chae Seung Lim

    Roles Conceptualization, Validation, Writing – review & editing

    pugae1@korea.ac.kr (DWP); malarim@korea.ac.kr (CSL)

    Affiliation Departments of Laboratory Medicine, College of Medicine, Korea University Guro Hospital, Seoul, Korea

    ⨯

Abstract

Severe fever with thrombocytopenia syndrome (SFTS) and scrub typhus are endemic zoonotic diseases that pose significant public health threats in East Asia. As these two diseases share common clinical features, as well as overlapping disease regions, it is difficult to differentiate between SFTS and scrub typhus. A multiplex reverse-transcription loop‑mediated isothermal amplification (RT-LAMP) assay was developed to detect large segments and GroES genes for SFTS virus (SFTSV) and Orientia tsutsugamushi (OT). The performance of the RT-LAMP assay was compared and evaluated with those of commercial PowerChek™ SFTSV real-time PCR and LiliF™ TSUTSU nested PCR for 23 SFTS and 12 scrub typhus clinical samples, respectively. The multiplex SFTSV/OT/Internal control (IC) RT-LAMP assay showed comparable sensitivity (91.3%) with that of commercial PowerChek™ SFTSV Real-time PCR (95.6%) and higher sensitivity (91.6%) than that of LiliF™ TSUTSU nested PCR (75%). In addition, the multiplex SFTSV/OT RT-LAMP assay showed 100% specificity and no cross-reactivity for blood from uninfected healthy patients and samples from patients infected with other fever viruses. Thus, the multiplex SFTSV/OT/IC RT-LAMP assay could serve as a useful point-of-care molecular diagnostic test for SFTS and scrub typhus.

Citation: Jang WS, Lim DH, Choe YL, Nam J, Moon KC, Kim C, et al. (2022) Developing a multiplex loop-mediated isothermal amplification assay (LAMP) to determine severe fever with thrombocytopenia syndrome (SFTS) and scrub typhus. PLoS ONE 17(2): e0262302. https://doi.org/10.1371/journal.pone.0262302

Editor: Shuang-yong Xu, New England Biolabs Inc, UNITED STATES

Received: July 22, 2021; Accepted: December 21, 2021; Published: February 16, 2022

Copyright: © 2022 Jang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Data Availability: All relevant data are within the paper and its Supporting information files.

Funding: This study was supported by a government-wide R&D fund project for infectious disease research (HG18C0012), National Research Foundation of Korea (NRF-2016R1A5A1010148), and a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HR20C0021 and HI20C0262030021).

Competing interests: NO authors have competing interests.

Introduction

Severe fever with thrombocytopenia syndrome (SFTS) and scrub typhus are endemic zoonotic diseases that are becoming significant public health threats in East Asia [1, 2]. The causative pathogen of SFTS is severe fever thrombocytopenia syndrome virus (SFTSV), which is a newly identified pathogenic member of the Phlebovirus species in the family Bunyaviridae [3]. The SFTSV is usually transmitted by ticks such as Haemophysalis longicornis during outdoor activities [4]. SFTS has been mainly reported in East Asian countries, including Korea, China, and Japan, with a high mortality rate (6.3–30%) [5–7]. The clinical features of SFTS are fever, headache, myalgia, and gastrointestinal symptoms, followed by thrombocytopenia and leukopenia [8].

Scrub typhus is caused by Orientia tsutsugamushi (OT), an obligate intracellular bacterium mediated by chigger mites such as Leptotrombidium species [9]. The distribution of scrub typhus is thought to be endemic to the region known as the “tsutsugamushi triangle,” which includes China, Japan, Indonesia, Malaysia, Thailand, Pakistan, Korea, northern Australia, and the islands of the western Pacific and Indian Ocean [10–12]. The mortality rate of scrub typhus is 1.4% [13], and the clinical course of scrub typhus is usually mild and self-limiting; however, delaying the treatment in severe cases can lead to complications such as renal failure, myocarditis, meningoencephalitis, and death [14–16]. Unfortunately, scrub typhus is characterized by symptoms such as fever, headache, myalgia, cough, and abdominal pain, which are difficult to differentiate from the symptoms of SFTS [8, 17]. Therefore, an incorrect diagnosis of patients with these symptoms followed by inadequate treatment can lead to death [18]. Therefore, it is necessary to differentiate and diagnose SFTS and Scrub typhus in the early stages [19].

Currently, the definitive diagnosis of scrub typhus and SFTS depends on laboratory-based diagnostic methods, including indirect immunofluorescent antibody test (IFA),​ enzyme-linked immunosorbent assay, immunochromatographic tests, and polymerase chain reaction (PCR) [20–23]. The current diagnostic criterion for scrub typhus is IFA testing [24]. However, single IFA measurements are sometimes insufficient for definitive diagnosis [12]. Recently, PCR has been developed and used for the early diagnosis of scrub typhus [25, 26]. For the diagnosis of SFTS, RT-PCR is mainly used but not standardized; therefore, it is difficult to diagnose SFTS quickly [27, 28]. In addition, since PCR tests are difficult to perform at regional hospitals due to lack of adequate resources, samples obtained from patients suspected of SFTS are mostly sent to the national laboratory, resulting in significant delays in PCR test results. Recently, a simple version of a practical molecular assay, the loop-mediated isothermal amplification (LAMP) assay was developed for use in resource-poor environments [29, 30]. This LAMP assay can be performed using simple equipment at a constant temperature, making it a fast and cost-effective point-of-care diagnostic test [31, 32]. In addition, inexpensive multi-channel isothermal amplifiers, such as Genie III (OptiGene, Horsham, UK) and T8-ISO (TwistDX, Cambridge, UK), have been developed and commercialized.

In this study, we developed a multiplex SFTSV/OT/IC loop‑mediated isothermal amplification (LAMP) assay for the differential diagnosis of SFTSV and O. tsutsugamushi infection, based on a slightly modified DARQ probe method [33, 34]. The detection limit of the multiplex SFTSV/OT/IC RT-LAMP assay was confirmed using diluted SFTS and scrub typhus clinical samples. The sensitivity and specificity of the RT-LAMP assay were compared and evaluated with those of the commercial PowerChek™ SFTSV Real-time PCR kit and LiliF™ TSUTSU nested PCR kit for SFTS and scrub typhus clinical samples, respectively.

Materials and methods

Clinical samples and nucleic acid extraction

We collected 35 clinical samples of serum and blood from 19 patients suspected of being infected with SFTSV (23 from 7 patients) and O. tsutsugamushi (12 from 12 patients) in the Republic of Korea. SFTS blood/serum samples (23) were collected on different days from hospitalized 7 SFTS patients. SFTS (23) and scrub typhus (12) clinical samples were confirmed using the SFTSV qRT-PCR and O. tsutsugamushi qPCR, which were previously reported by Yoshikawa et. al. [35] and Tantibhedhyangkul et. al. [26], respectively. To assess the specificity of the multiplex SFTSV/OT/IC RT-LAMP assay, 100 clinical sample specimens from individuals with (38) and without (62) other viral infections were tested. Viral infection samples, as confirmed via PCR using qRT-PCR [36–38] and the Anyplex™ II RV16 detection kit (Seegene, Seoul, South Korea), included 1 Hantaan virus, 4 Dengue virus (1–4), 1 Chikungunya virus, 4 influenza virus A/H1N1, 4 influenza virus A/H3N2, 4 influenza virus B, 4 respiratory syncytial virus (RSV) A, 4 RSV B, and 12 coronaviruses (KHU1, NL63, 229E). Nucleic acids (DNA and RNA), were extracted from 200 μL of clinical blood or serum samples using the cell DNA/RNA/NA kit (Genolution, Seoul, Korea) with Nextractor® NX-48S (Genolution, Seoul, Korea), according to the manufacturer’s instructions. Nucleic acid samples were stored at -50 ºC before further testing. This study was approved by the Medical Ethics Committee of Korea University Guro Hospital (IRB No. 2020GR0556). Informed consent was waived by the institutional review board (IRB) because this study used residual samples.

Primer design

The RT-LAMP primer sets for SFTSV and O. tsutsugamushi were designed from the conserved regions of the L segment and groES genes (Table 1). The actin beta gene in humans was used as an internal control (IC), as previously reported [39]. All LAMP primers including two outer primers (forward primer F3 and backward primer B3), two inner primers (forward inner primer FIP and backward inner primer BIP), and two loop primers (forward loop primer LF and backward loop primer LB) were designed using the Primer Explorer v4 software (Eiken Chemical Co., Tokyo, Japan). For multiple LAMPs, we used a slightly modified DARQ probe method. Briefly, a dye-labeled artificial nucleic acid + FLP sequence probe and a quencher-labeled displacement probe complementary to the artificial nucleic acid sequence were used. In this study, two types of artificial nucleic acids (32mers and 35mers) were used for multiplexing different fluorescence (FAM/Hex and Cy5) quenched by BHQ1 and BHQ2, respectively. A FAM (or Hex)-labeled 32-artificial oligomer-SFTS (or IC) FLP was designed for SFTS (or IC) FLP probe 1 and a Cy5-labeled 35-artificial oligomer-OT FLP was designed for tsu FLP probe 2. The quencher-labeled 30-oligonucleotide (BHQ1) or 35-oligonucleotide (BHQ2) was complementary to artificial nucleic acids sequences of SFTS (or IC) FLP probe 1 and tsu FLP probe 2, respectively. Before use in LAMP, all primers were assessed for specificity by performing a BLAST search. All LAMP primers and probes were synthesized by Macrogen (Seoul, South Korea).

thumbnail
Download:
Table 1. The multiplex SFTSV/OT/IC RT-LAMP primer sets.

https://doi.org/10.1371/journal.pone.0262302.t001

Real-time RT-PCR

To confirm SFTS and scrub typhus positive clinical samples, the SFTSV L, M, and S gene qRT-PCR primer sets [35] and O. tsutsugamushi groEL gene qPCR primer set [26] were used, and PCR conditions were set according to the protocol described by Yoshikawa et al., and Tantibhedhyangkul et al., respectively. The thermocycling parameters of the SFTSV L segment gene qRT-PCR were used as follows: after incubation at 95°C for 2 min, a reverse transcription step was performed at 55°C for 30 min, followed by 45 cycles of 94°C for 30 s, 52°C for 30 s with fluorescence detection, and 68°C for 30 s. The PCR cycling conditions for O. tsutsugamushi groEL gene qPCR were as follows: initial denaturation and hot-start enzyme activation at 95°C for 3 min, followed by 45 cycles of denaturation at 95°C for 1 s, combined annealing/extension at 58°C for 30 s with data acquisition for 12 s, and extension at 70°C for 3 s. PowerChek™ SFTSV Real-time PCR and LiliF™ TSUTSU nested PCR were carried out according to a manufacture’s protocol.

Multiplex RT-LAMP

For multiplex SFTSV/OT/IC RT-LAMP assay, the reaction mixture was prepared with 12.5 μL of 2× reaction buffer, 1.25 μL of SFTSV LAMP primer mix (20x), 1.5 μL of OT LAMP primer mix (20x), 0.625 μL of IC (actin β) LAMP primer mix (20x), 1.875 μL of 9 μM quencher 1 solution for quenching the SFTS and IC LAMP probe, 1.5 μL of 9 μM quencher 2 solution for quenching the OT LAMP probe, and 5 μL of sample RNA (with a final reaction volume of 25 μL). The compositions of all LAMP primer mix (20x) were 4 μM of two outer primers (F3 and B3) and 32 μM of two inner primers (FIP and BIP), 10 μM of loop BLP primer, 4 μM loop FLP primer, and 6 μM loop FLP probe primer. The RT-LAMP assay was run on a CFX 96 Touch Real-Time PCR Detection System (Bio-Rad Laboratories, Hercules, CA, USA) at 62ºC for 40 min. The FAM, Hex, and Cy5 fluorescence channels were used to detect SFTSV, IC, and O. tsutsugamushi, respectively. For comparative studies, the performance of multiplex SFTSV/OT/IC LAMP assays was compared with that of commercial PowerChek™ SFTSV Real-time PCR kit and LiliF™ TSUTSU nested PCR Kit. The RT-LAMP assay was performed using the RT-LAMP 2× Master Mix (ELPIS-Biotech, Daejeon, South Korea).

Limits of detection

pTOP Blunt V2 plasmids, including partial L segment gene sequences of SFTSV and groES gene sequences of O. tsutsugamushi, were used to test the limit of detection (LOD) of the RT-LAMP assay. All plasmids were constructed by Macrogen. To determine the LOD of the monoplex SFTSV RT-LAMP, monoplex OT RT-LAMP, and multiplex SFTSV/OT/IC RT-LAMP assays, the plasmids were serially diluted 10-fold from 1 × 106 to 1 × 100 copies/μL. This test was repeated 3 times. In addition, the LODs of the monoplex SFTSV RT-LAMP, monoplex OT RT-LAMP, and multiplex SFTSV/OT/IC RT-LAMP assays were compared with those of the commercial PowerChek™ SFTSV Real-time PCR kit and LiliF™ TSUTSU nested PCR kit for 2-fold serial dilutions of clinical samples from patients infected with SFTSV or O. tsutsugamushi. According to FDA EUA guidelines for COVID-19 diagnostic tests, the LODs of the monoplex SFTSV RT-LAMP, monoplex OT RT-LAMP, and multiplex SFTSV/OT/IC RT-LAMP assays were determined as the minimum concentration in a 2-fold dilution series at which 19 of 20 replicates amplify [40, 41]. the LODs of commercial PowerChek™ SFTSV Real-time PCR kit and LiliF™ TSUTSU nested PCR kit were repeated five times and determined as the minimum concentration in a 2-fold dilution series at which 5 of 5 replicates amplify.

Results

Optimization of multiplex SFTSV/OT/IC RT-LAMP assay

The sensitivities of the monoplex SFTSV (FAM) and monoplex OT (Hex) RT-LAMP assay using strand-displaceable probes were evaluated by testing synthetic plasmid standards, including synthetic partial L segment gene of SFTSV and groES genes of O. tsutsugamushi ranging from 106 to 100 copies/μL, respectively. The limits of detection of monoplex SFTSV RT-LAMP and monoplex OT RT-LAMP were 1x102 copies/μL and 1x101 copies/μL, respectively (Table 2). For optimization of multiplex SFTSV /OT (Cy5)/IC (Hex) RT-LAMP assays, different ratios (1.5:2:0.6, 1.5:1.5:0.6 and 2:1.5:0.6) of LAMP primers set (vol, μL/ 25 μL reaction) were tested at 62ºC with synthetic plasmids including partial L segment gene of SFTSV and groES genes of O. tsutsugamushi (Fig 1A). For internal control (IC), actin beta LAMP primer set was used for the human actin beta gene amplification (Table 1). In SFTSV signal detection, a ratio of 1.5:1.5:0.6 showed faster Ct values (8.27) than others (1.5:2:0.6 = 8.94 and 2:1.5:0.6 = 8.30). In OT signal detection, a ratio of 1.5:2:0.6 showed faster Ct values (7.84) than others (1.5:1.5:0.6 = 9.18 and 2:1.5:0.6 = 9.59). Comprehensively considering the ct values and RFUs, the 1.5:2:0.6 ratio of the SFTS/OT/IC LAMP primer set was finally determined. Next, temperature-gradient tests (59, 62 and 65ºC) showed that the optimum temperature was 62ºC for multiplex SFTSV/OT/IC RT-LAMP assay (Fig 1B). Finally, in LOD test, the multiplex SFTSV/OT/IC RT-LAMP assay showed the same detection limit of monoplex SFTSV and OT RT-LAMP primer set for synthetic SFTSV and OT plasmid standards (Table 2).

thumbnail
Download:
Fig 1. Optimization of the multiplex SFTSV/OT/IC LAMP primer set.

(A) Different concentration ratios of SFTSV, OT, and IC primer sets (1.5:2:0.6, 1.5:1.5:0.6, and 2:1.5:0.6, respectively) for SFTSV, OT, and IC plasmid mixtures (1:1:1). (B) Temperature gradient tests (59–65°C) of the multiplex SFTSV/OT/IC LAMP assay.

https://doi.org/10.1371/journal.pone.0262302.g001

thumbnail
Download:
Table 2. Limit of detection test for the monoplex and multiplex SFTSV/OT/IC LAMP primer set.

https://doi.org/10.1371/journal.pone.0262302.t002

Comparison of detection limits of the multiplex SFTSV/OT/IC RT-LAMP assay with those of commercial kits for serial diluted SFTS and scrub typhus clinical samples

The LODs of the monoplex and multiplex SFTSV/OC/IC LAMP primer sets were compared to those of two commercial kits, the PowerChek™ SFTSV Real-time PCR kit (Kogene Biotech, Seoul, Korea) and LiliF™ TSUTSU nested PCR kit (iNtRON, Seongnam-Si, South Korea), for 2-fold serial diluted SFTSV serum samples and scrub typhus blood samples (range 28–215 and 21−28, respectively) (Table 3). For serial two-fold diluted SFTS clinical samples, monoplex and PowerChekTM SFTSV Real-time PCR kit showed the same LODs of 210, whereas the LOD of multiplex SFTSV/OC/IC LAMP assay was 212, which is one step lower than results of others. However, for scrub typhus clinical samples, both of the monoplex and multiplex SFTSV/OC/IC LAMP assay showed the superior LOD (25) to that (23) of the LiliFTM TSUTSU nested PCR kit.

thumbnail
Download:
Table 3. Limit of detection tests of the multiplex SFTSV/OT/IC RT-LAMP assay, PowerChek™ SFTSV Real-time PCR kit and LiliF™ TSUTSU nested PCR kit for two-fold diluted clinical samples from patients infected with SFTSV or O. tsutsugamushi.

https://doi.org/10.1371/journal.pone.0262302.t003

Comparison of the clinical performance of the multiplex SFTSV/OT/IC RT-LAMP assay with those of the commercial PowerChek™ SFTSV Real-time PCR kit and LiliF™ TSUTSU nested PCR kit using clinical samples

To confirm the clinical performance of the multiplex SFTSV/OT/IC RT-LAMP assay, the sensitivities of the assays were compared to those of the commercial PowerChek™ SFTSV Real-time PCR kit and LiliF™ TSUTSU nested PCR kit for 35 clinical samples from patients infected with SFTSV (23) and O. tsutsugamushi (12). For the specificities of these three assays, 100 clinical sample specimens from individuals with (38) and without (62) other viral infections were used (Table 4). For the SFTS clinical samples (n = 23), the sensitivity of the PowerChek™ SFTSV Real-time PCR kit was 95.6% (S gene: 95.6%, and M genes: 86.9%). The sensitivity of the multiplex SFTSV/OT/IC RT-LAMP assay was 91.3%. For scrub typhus clinical samples (n = 12), the sensitivity of the LiliF™ TSUTSU nested PCR kit was 75% and that of the multiplex SFTSV/OT/IC RT-LAMP assay was 91.6%. Overall, the multiplex SFTSV/OT/IC RT-LAMP assay showed similar sensitivities to that of the commercial PowerChek™ SFTSV Real-time PCR kit and superior sensitivity to the LiliF™ TSUTSU nested PCR kit. For 100 negative clinical samples (non-infection/other viral infections; n = 64/38), the specificity of the two assays was 100%, except for the LiliF™ TSUTSU nested PCR kit (98%) (Table 4).

thumbnail
Download:
Table 4. Comparison of clinical performance between the multiplex SFTSV/OT/IC RT-LAMP assay, PowerChek™ SFTSV Real-time PCR kit, and LiliF™ TSUTSU nested PCR kit for clinical samples from patients infected with SFTSV or O. tsutsugamushi.

https://doi.org/10.1371/journal.pone.0262302.t004

Cross-reactivity tests of SFTSV/OT/IC RT-LAMP assay with other fever viruses

To confirm the absence of cross-reactivity with other common fever viruses, a total of 38 viral RNA samples, including Hantaan virus, Dengue virus, chikungunya virus, influenza virus A, influenza virus B, RSV A, RSV B, coronavirus 229E, NL63, and OC43, were tested using the multiplex SFTSV/OT/IC RT-LAMP assay (Table 5). As a result, the multiplex SFTSV/OT/IC RT-LAMP assay did not show cross-reactivity for all the tested samples.

thumbnail
Download:
Table 5. Cross-reactivity of the multiplex SFTSV/OT/IC RT-LAMP assay against other fever infectious viruses.

https://doi.org/10.1371/journal.pone.0262302.t005

Discussion

Severe fever with thrombocytopenia syndrome virus (SFTSV) and O. tsutsugamushi are not transmitted by the same vectors; however, these two diseases share a common point as they are transmitted by arthropod bites mostly during outdoor activities [18, 42]. In addition, these two diseases share common clinical features, such as fever, nausea, vomiting, diarrhea, headache, and muscle pain, as well as overlapping disease regions. Furthermore, many cases of co-infection with SFTSV and O. tsutsugamushi have been reported [43–45].

Here, we developed a multiplex SFTSV/OT/IC RT-LAMP assay to detect SFTSV L segment, groES, and actin beta genes. In sensitivity tests for SFTS and scrub typhus clinical samples, the multiplex SFTSV/OT/IC RT-LAMP assay showed 91.3% and 91.6% for SFTS (n = 23) and scrub typhus (n = 12) clinical samples, respectively. These results are comparable to those (M gene: 86.9% and S gene: 95.6%) of the commercial PowerChek™ SFTSV Real-time PCR, and superior to 75% of LiliF™ TSUTSU nested PCR kit. The sensitivity and specificity results of PowerChek™ SFTSV Real-time PCR were within the scope of previous results (sensitivity: 100% (CI: 73.2%–100%) and sensitivity: 98.1% (CI: 92.5%–99.7%)) reported by Yoo. et al [46]. Therefore, the results of this test are considered reliable, although they were tested with a small number of samples. In addition, the LODs for the multiplex SFTSV/OT/IC RT-LAMP for diluted SFTS and scrub typhus clinical samples were the same as those of the PowerChek™ SFTSV Real-time PCR and LiliF™ TSUTSU nested PCR kit, respectively.

To simultaneously detect SFTSV and O. tsutsugamushi, nucleic acid (DNA/RNA) extraction from whole blood is an important step in multiplex SFTSV/OT/IC RT-LAMP assay. Here, Nextractor® NX-48S, which is an automated nucleic acid extraction instrument, was used for fast (within 20 min) and contamination-free extraction of nucleic acids from serum or whole blood. Unfortunately, the multiplex SFTSV/OT/IC RT-LAMP assay could not detect OT signals with nucleic acids (DNA/RNA) extracted from the serum of patients infected with O. tsutsugamushi. This may be because O. tsutsugamushi is present at low concentrations in the serum. In fact, most of the O. tsutsugamushi qPCR and LAMP assays developed to date were performed using DNA extracted from whole blood, buffy coat, and eschars of patients infected with O. tsutsugamushi [30, 47, 48]. In the sensitivity test, we used 24 SFTS serum clinical samples to confirm the performance of the multiplex SFTSV/OT/IC RT-LAMP assay because of the small number of SFTS whole blood samples. Thus, to confirm whether the multiplex SFTSV/OT/IC RT-LAMP assay can detect SFTSV in whole blood samples, an additional 12 whole blood samples, which were matched with the positive SFTS serum sample, were tested and confirmed to be positive in the multiplex SFTSV/OT/IC RT-LAMP assay (S1 Table).

Our study has some limitations. First, the multiplex SFTSV/OT/IC RT-LAMP assay was performed with a relatively small sample size of positive SFTS (23) and scrub typhus (12) clinical samples, which resulted in widened confidence intervals for our estimates of diagnostic accuracy. However, considering that the multiplex SFTSV/OT/IC RT-LAMP assay showed the same or higher sensitivity compared to the two commercially available diagnostic kits, and 100% specificity to the negative samples, the multiplex SFTSV/OT/IC RT-LAMP assay is sufficiently competitive in commercial development. In addition, it can be applied quickly and cost-effectively, particularly in the early stages of fever in patients in endemic areas. Second, in SFTS LOD test, we used SFTS DNA plasmid as a standard material for LOD test of the multiplex SFTSV/OT/IC RT-LAMP assay. However, there is the deficiency of characterizing an RT-LAMP assay with a DNA standard because it cannot confirm the function of reverse transcriptase. Thus, using SFTS and scrub typhus clinical samples, we reconfirmed the limit of detection of monoplex and multiplex SFTSV/OT/IC RT-LAMP assay compared to those of commercial LiliF™ TSUTSU nested PCR and PowerChekTM SFTSV Real-time PCR kit.

In this study, we developed a multiplex SFTSV/OT/IC RT-LAMP assay capable of simultaneous diagnosis of SFTS and scrub typhus within 40 min. For sensitivity and specificity tests with SFTS and scrub typhus clinical samples, the multiplex SFTSV/OT/IC RT-LAMP assay showed similar or superior performance compared with commercial PowerChek™ SFTSV Real-time PCR and LiliF™ TSUTSU nested PCR. Thus, the multiplex SFTSV/OT/IC RT-LAMP assay could serve as a useful point-of-care molecular diagnostic test for SFTS and scrub typhus.

Supporting information

S1 Table. Sensitivities the multiplex SFTSV/OT/IC RT-LAMP assay for whole blood SFTS clinical samples.

https://doi.org/10.1371/journal.pone.0262302.s001

(DOCX)

S1 File. Raw data.

https://doi.org/10.1371/journal.pone.0262302.s002

(XLSX)

References

  1. 1. Kirino Y, Ishijima K, Miura M, Nomachi T, Mazimpaka E, Sudaryatma PE, et al. Seroprevalence of severe fever with thrombocytopenia syndrome virus in small-animal veterinarians and nurses in the Japanese Prefecture with the highest case load. Viruses. 2021;13: 229. Epub 2021/02/06. pmid:33540629.
  2. 2. Elliott I, Pearson I, Dahal P, Thomas NV, Roberts T, Newton PN. Scrub typhus ecology: a systematic review of Orientia in vectors and hosts. Parasites & vectors. 2019;12: 513. pmid:31685019
  3. 3. Yu XJ, Liang MF, Zhang SY, Liu Y, Li JD, Sun YL, et al. Fever with thrombocytopenia associated with a novel bunyavirus in China. N Engl J Med. 2011;364: 1523–1532. pmid:21410387
  4. 4. Chung JK, Kim CM, Kim DM, Yun NR, Park JW, Seo J, et al. Severe fever with thrombocytopenia syndrome associated with manual de-ticking of domestic dogs. Vector Borne Zoonotic Dis. 2020;20: 285–294. pmid:32045336
  5. 5. Ding F, Zhang W, Wang L, Hu W, Soares Magalhaes RJ, Sun H, et al. Epidemiologic features of severe fever with thrombocytopenia syndrome in China, 2011–2012. Clin Infect Dis. 2013;56: 1682–1683. pmid:23429379
  6. 6. Yun SM, Park SJ, Kim YI, Park SW, Yu MA, Kwon HI, et al. Genetic and pathogenic diversity of severe fever with thrombocytopenia syndrome virus (SFTSV) in South Korea. JCI Insight. 2020;5: e129531. pmid:31877113
  7. 7. Silvas JA, Aguilar PV. The emergence of severe fever with thrombocytopenia syndrome virus. Am J Trop Med Hyg. 2017;97: 992–996. pmid:28820686
  8. 8. Choi SJ, Park SW, Bae IG, Kim SH, Ryu SY, Kim HA, et al. Severe fever with thrombocytopenia syndrome in South Korea, 2013–2015. PLoS Negl Trop Dis. 2016;10: e0005264. pmid:28033338
  9. 9. Kim G, Ha NY, Min CK, Kim HI, Yen NT, Lee KH, et al. Diversification of Orientia tsutsugamushi genotypes by intragenic recombination and their potential expansion in endemic areas. PLoS Negl Trop Dis. 2017;11: e0005408. pmid:28248956
  10. 10. Jiang J, Richards AL. Scrub typhus: no longer restricted to the tsutsugamushi triangle. Trop Med Infect Dis. 2018;3: 11. pmid:30274409
  11. 11. Janardhanan J, Trowbridge P, Varghese GM. Diagnosis of scrub typhus. Expert Rev Anti Infect Ther. 2014;12: 1533–1540. pmid:25359599
  12. 12. Blacksell SD, Bryant NJ, Paris DH, Doust JA, Sakoda Y, Day NP. Scrub typhus serologic testing with the indirect immunofluorescence method as a diagnostic gold standard: a lack of consensus leads to a lot of confusion. Clin Infect Dis. 2007;44: 391–401. pmid:17205447
  13. 13. Bonell A, Lubell Y, Newton PN, Crump JA, Paris DH. Estimating the burden of scrub typhus: a systematic review. PLoS Negl Trop Dis. 2017;11: e0005838. pmid:28945755
  14. 14. Kim DM, Kim SW, Choi SH, Yun NR. Clinical and laboratory findings associated with severe scrub typhus. BMC Infect Dis. 2010;10: 108. pmid:20433689
  15. 15. Chrispal A, Boorugu H, Gopinath KG, Prakash JA, Chandy S, Abraham OC, et al. Scrub typhus: an unrecognized threat in South India—clinical profile and predictors of mortality. Trop Doct. 2010; 40: 129–133. pmid:20360426
  16. 16. Crecelius EM, Burnett MW. Scrub Typhus. J Spec Oper Med. 2020;20: 120–122. Epub 2020/03/24. pmid:32203616.
  17. 17. Rajapakse S, Weeratunga P, Sivayoganathan S, Fernando SD. Clinical manifestations of scrub typhus. Trans R Soc Trop Med Hyg. 2017;111: 43–54. pmid:28449088
  18. 18. Park SW, Lee CS, Kim JH, Bae IG, Moon C, Kwak YG, et al. Severe fever with thrombocytopenia syndrome: comparison with scrub typhus and clinical diagnostic prediction. BMC Infect Dis. 2019;19: 174. pmid:30782137
  19. 19. Yun JH, Hwang HJ, Jung J, Kim MJ, Chong YP, Lee SO, et al. Comparison of chest radiographic findings between severe fever with thrombocytopenia syndrome and scrub typhus: Single center observational cross-sectional study in South Korea. Medicine. 2019;98: e17701. pmid:31725613
  20. 20. Seo JW, Kim D, Yun N, Kim DM. Clinical update of severe fever with thrombocytopenia syndrome. Viruses. 2021;13: 1213. pmid:34201811
  21. 21. Chakraborty S, Sarma N. Scrub typhus: an emerging threat. Indian J Dermatol. 2017;62: 478–485. pmid:28979009
  22. 22. Li DX. Severe fever with thrombocytopenia syndrome: a newly discovered emerging infectious disease. Clin Microbiol Infect. 2015;21: 614–620. pmid:25769426
  23. 23. Kala D, Gupta S, Nagraik R, Verma V, Thakur A, Kaushal A. Diagnosis of scrub typhus: recent advancements and challenges. 3 Biotech. 2020;10: 396. pmid:32834918
  24. 24. Pradutkanchana J, Silpapojakul K, Paxton H, Pradutkanchana S, Kelly DJ, Strickman D. Comparative evaluation of four serodiagnostic tests for scrub typhus in Thailand. Trans R Soc Trop Med Hyg. 1997;91: 425–428. pmid:9373640
  25. 25. Kim DM, Park G, Kim HS, Lee JY, Neupane GP, Graves S, et al. Comparison of conventional, nested, and real-time quantitative PCR for diagnosis of scrub typhus. J Clin Microbiol. 2011;49: 607–612. pmid:21068287
  26. 26. Tantibhedhyangkul W, Wongsawat E, Silpasakorn S, Waywa D, Saenyasiri N, Suesuay J, et al. Use of multiplex real-time PCR to diagnose scrub typhus. J Clin Microbiol. 2017;55: 1377–1387. pmid:28202789
  27. 27. Sun Y, Liang M, Qu J, Jin C, Zhang Q, Li J, et al. Early diagnosis of novel SFTS bunyavirus infection by quantitative real-time RT-PCR assay. J Clin Virol. 2012;53: 48–53. pmid:22024488
  28. 28. Augustine R, Hasan A, Das S, Ahmed R, Mori Y, Notomi T, et al. Loop-mediated isothermal amplification (LAMP): a rapid, sensitive, specific, and cost-effective point-of-care test for coronaviruses in the context of COVID-19 pandemic. Biology (Basel). 2020;9: 182. pmid:32707972
  29. 29. Sano S, Fukushi S, Yamada S, Harada S, Kinoshita H, Sugimoto S, et al. Development of an RT-LAMP assay for the rapid detection of SFTS virus Viruses. 2021;13: 693. pmid:33923720
  30. 30. Paris DH, Blacksell SD, Newton PN, Day NP. Simple, rapid and sensitive detection of Orientia tsutsugamushi by loop-isothermal DNA amplification. Trans R Soc Trop Med Hyg. 2008;102: 1239–1246. pmid:18565558
  31. 31. Baek YH, Cheon HS, Park SJ, Lloren KKS, Ahn SJ, Jeong JH, et al. Simple, rapid and sensitive portable molecular diagnosis of SFTS virus using reverse transcriptional loop-mediated isothermal amplification (RT-LAMP). J Microbiol Biotechnol. 2018;28:1928–1936. pmid:30270605
  32. 32. Nagamine K, Hase T, Notomi T. Accelerated reaction by loop-mediated isothermal amplification using loop primers. Mol Cell Probes. 2002;16: 223–229. pmid:12144774
  33. 33. Bhat IA, Mashooq M, Kumar D, Varshney R, Rathore R. Development of probe-based real-time loop-mediated isothermal amplification for detection of Brucella. J Appl Microbiol. 2019;126: 1332–1339. pmid:29851222
  34. 34. Tanner NA, Zhang Y, Evans TC Jr. Simultaneous multiple target detection in real-time loop-mediated isothermal amplification. Biotechniques. 2012;53: 81–89. pmid:23030060
  35. 35. Yoshikawa T, Fukushi S, Tani H, Fukuma A, Taniguchi S, Toda S, et al. Sensitive and specific PCR systems for detection of both Chinese and Japanese severe fever with thrombocytopenia syndrome virus strains and prediction of patient survival based on viral load. J Clin Microbiol. 2014;52: 3325–3333. pmid:24989600.
  36. 36. Sui X, Zhang X, Fei D, Zhang Z, Ma M. Simultaneous rapid detection of Hantaan virus and Seoul virus using RT-LAMP in rats. PeerJ. 2019;6: e6068. pmid:30643674
  37. 37. Jang WS, Kwak SY, May WL, Yang DJ, Nam J, Lim CS. Comparative evaluation of three dengue duo rapid test kits to detect NS1, IgM, and IgG associated with acute dengue in children in Myanmar. PLoS One. 2019;14: e0213451. pmid:30865680
  38. 38. Patel P, Abd El Wahed A, Faye O, Prüger P, Kaiser M, Thaloengsok S, et al. A field-deployable reverse transcription recombinase polymerase amplification assay for rapid detection of the chikungunya virus. PLoS Negl Trop Dis. 2016;10: e0004953. pmid:27685649
  39. 39. Jang WS, Lim DH, Nam J, Mihn DC, Sung HW, Lim CS, et al. Development of a multiplex isothermal amplification molecular diagnosis method for on-site diagnosis of influenza. PLoS One. 2020;15: e0238615. pmid:32915821
  40. 40. FDA. COVID-19 in vitro diagnostics emergency use authorizations. [cited Dec 2020]. https://www.fda.gov/medical-evices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/vitro-diagnostics-euas#individual-molecular.
    • 41. Moehling TJ, Choi G, Dugan LC, Salit M, Meagher RJ. LAMP diagnostics at the point-of-care: Emerging trends and perspectives for the developer community. Expert Review of Molecular Diagnostics. 2021;21: 43–61. pmid:33474990
    • 42. Kim JH, Lee CS, Moon C, Kwak YG, Kim BN, Kim ES, et al. Co-Infection of scrub typhus and human granulocytic anaplasmosis in Korea, 2006. J Korean Med Sci. 2019;34: e257. pmid:31602827
    • 43. Wi YM, Woo HI, Park D, Lee KH, Kang CI, Chung DR, et al. Severe fever with thrombocytopenia syndrome in patients suspected of having scrub typhus. Emerg Infect Dis. 2016;22: 1992–1995. pmid:27767909
    • 44. Thi Hai Yen N, Kim C, Jeong S, Jeon K, Choi H, Ro HJ, et al. Severe fever with thrombocytopenia syndrome virus infection or mixed infection with scrub typhus in South Korea in 2000–2003. Am J Trop Med Hyg. 2019;101: 1096–1099. pmid:31482787
    • 45. Ra SH, Kim JY, Cha HH, Kwon JS, Lee HJ, Jeon NY, et al. Coinfection of severe fever with thrombocytopenia syndrome and scrub typhus in patients with tick-borne illness. Am J Trop Med Hyg. 2019;101: 1259–1262. pmid:31549609
    • 46. Yoo IY, Kim JY, Yoon YK, Huh HJ, Lee NY. Comparison between the SFTS-QS kit and the PowerChek SFTSV real-time PCR kit for the detection of severe fever with thrombocytopenia syndrome virus. Ann Lab Med. 2020;40: 317–320. pmid:32067431
    • 47. Watthanaworawit W, Turner P, Turner C, Tanganuchitcharnchai A, Richards AL, Bourzac KM, et al. A prospective evaluation of real-time PCR assays for the detection of Orientia tsutsugamushi and Rickettsia spp. for early diagnosis of rickettsial infections during the acute phase of undifferentiated febrile illness. Am J Trop Med Hyg. 2013;89: 308–310. pmid:23732256
    • 48. Le Viet N, Laroche M, Thi Pham HL, Viet NL, Mediannikov O, Raoult D, et al. Use of eschar swabbing for the molecular diagnosis and genotyping of Orientia tsutsugamushi causing scrub typhus in Quang Nam province, Vietnam. PLoS Negl Trop Dis. 2017;11: e0005397. pmid:28241043